260P - PAM50 and CGH-array genomic characterization of HER2-equivocal breast cancers defined by the 2018 ASCO/CAP recommendations.
Saved in:
| Title: | 260P - PAM50 and CGH-array genomic characterization of HER2-equivocal breast cancers defined by the 2018 ASCO/CAP recommendations. |
|---|---|
| Authors: | Ngo, C.1 (AUTHOR), Borcoman, E.2 (AUTHOR), Rapinat, A.3 (AUTHOR), Simaga, F.1 (AUTHOR), Mouterfi, N.1 (AUTHOR), Mariani, O.4 (AUTHOR), Fuhrmann, L.1 (AUTHOR), Jeannot, E.1 (AUTHOR), Lae, M.1 (AUTHOR), Pierga, J.-Y.5 (AUTHOR), Gentien, D.3 (AUTHOR), Pierron, G.1 (AUTHOR), Morel, P.6 (AUTHOR), Brauer, H.A.6 (AUTHOR), Vincent-Salomon, A.4 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement 6, Vol. 30, pv87-v87. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdz240.084 |
